Prokidney to participate in jefferies biotech on the bay summit

Winston-salem, n.c., feb. 29, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that senior members of the management team will be participating in the jefferies biotech on the bay summit being held in miami on march 12 – 13, 2024.
PROK Ratings Summary
PROK Quant Ranking